Yilmaz Candeger | Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
スポンサーリンク
概要
- YILMAZ CANDEGERの詳細を見る
- 同名の論文著者
- Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Egeの論文著者
関連著者
-
Yilmaz Candeger
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Karadeniz Muammer
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Saygili Fusun
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Kabalak Taylan
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Ozgen Ahmet
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
ZENGI AYHAN
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ege
-
KARADENIZ MUAMMER
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ege
-
ERDOGAN MEHMET
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ege
-
Erdogan Mehmet
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Zengi Ayhan
Division Of Endocrinology And Metabolism Department Of Internal Medicine University Of Ege
-
Yilmaz Candeger
Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University Hospital
-
Cetinkalp Sevki
Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University Hospital
-
Tobu Mahmut
Division of Hematology, Department of Internal Medicine, Ege University Hospital
-
Buyukkeçeci Filiz
Division of Hematology, Department of Internal Medicine, Ege University Hospital
-
Karadeniz Muammer
Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University Hospital
著作論文
- Does Chernobyl Accident Have Any Effect on Thyroid Cancers in Turkey? a Retrospective Review of Thyroid Cancers from 1982 to 2006
- The Effect of Hormone Replacement Treatment on Thrombin-Activatable Fibrinolysis Inhibitor Activity Levels in Patients with Hashimoto Thyroiditis